2seventy Bio Agrees To Be Acquired By Bristol Myers Squibb For $5.00/shr; Stock Up
(RTTNews) - 2seventy bio Inc. (TSVT) agreed to be acquired by Bristol Myers Squibb (BMY) at a price of $5.00 per share in an all-cash transaction. This acquisition values the total equity at approximately $286 million, or $102 million net of estimated cash. The deal represents an
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
